Aptose Biosciences Inc (APTO)
1.18
-0.01
(-0.84%)
USD |
NASDAQ |
May 17, 16:00
1.15
-0.03
(-2.54%)
After-Hours: 20:00
Aptose Biosciences Shareholders Equity (Quarterly): 0.137M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.137M |
December 31, 2023 | -2.901M |
September 30, 2023 | 7.776M |
June 30, 2023 | 13.79M |
March 31, 2023 | 25.99M |
December 31, 2022 | 37.74M |
September 30, 2022 | 46.81M |
June 30, 2022 | 55.49M |
March 31, 2022 | 65.28M |
December 31, 2021 | 74.24M |
September 30, 2021 | 88.68M |
June 30, 2021 | 98.18M |
March 31, 2021 | 109.41M |
December 31, 2020 | 118.92M |
September 30, 2020 | 129.16M |
June 30, 2020 | 79.22M |
March 31, 2020 | 87.24M |
December 31, 2019 | 93.93M |
September 30, 2019 | 27.43M |
June 30, 2019 | 33.76M |
March 31, 2019 | 15.42M |
December 31, 2018 | 14.08M |
September 30, 2018 | 13.92M |
June 30, 2018 | 16.89M |
March 31, 2018 | 14.47M |
Date | Value |
---|---|
December 31, 2017 | 10.20M |
September 30, 2017 | 9.876M |
June 30, 2017 | 10.29M |
March 31, 2017 | 7.751M |
December 31, 2016 | 7.328M |
September 30, 2016 | 6.898M |
June 30, 2016 | 9.067M |
March 31, 2016 | 11.06M |
December 31, 2015 | 13.65M |
September 30, 2015 | 16.86M |
June 30, 2015 | 20.07M |
March 31, 2015 | 21.59M |
September 30, 2014 | 28.61M |
May 31, 2014 | 26.21M |
February 28, 2014 | 3.637M |
November 30, 2013 | -1.492M |
August 31, 2013 | -1.631M |
May 31, 2013 | -0.7578M |
February 28, 2013 | 0.3917M |
November 30, 2012 | 1.644M |
August 31, 2012 | 3.129M |
May 31, 2012 | -1.968M |
February 29, 2012 | -1.077M |
November 30, 2011 | -0.0659M |
August 31, 2011 | 1.090M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.901M
Minimum
Dec 2023
129.16M
Maximum
Sep 2020
59.51M
Average
60.39M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.80M |
Total Liabilities (Quarterly) | 12.66M |